Advances in PEGylation of important biotech molecules: Delivery aspects

Expert Opinion on Drug Delivery

Volumn 5, Issue 4, 2008, Pages 371-383

  Ryan, Sinéad M ^a   Mantovani, Giuseppe ^b   Wang, Xuexuan ^a   Haddleton, David M ^b   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Drug delivery; PAMAM dendrimers; PEG; PEGylated liposomes; PEGylation

Indexed keywords

AERX; AIR INSULIN; ALSTERPAULLONE; ASPARAGINASE MACROGOL; BIOAIR; BISPHOSPHONIC ACID DERIVATIVE; CERTOLIZUMAB PEGOL; DENDRIMER; DIMETICONE; DOXORUBICIN; DRUG CARRIER; FILGASTRIM; FLUOROURACIL; INSULIN; LIPOSOME; LYSINE; MACROGOL; METHOTREXATE; NANOPARTICLE; PACLITAXEL; PEGADEMASE; PEGFILGASTRIM; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PEGVISOMANT; POLY(N ISOPROPYLACRYLAMIDE); POLYAMIDOAMINE; REBETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT HUMAN INSULIN; RECOMBINANT PROTEIN; RIBAVIRIN; SALCATONIN; SMALL INTERFERING RNA; STREPTAVIDIN; TECHNOSPHERE; TRANSFERRIN; UNINDEXED DRUG;

AEROSOL; ANTIGENICITY; BIOCOMPATIBILITY; BIOTECHNOLOGICAL PRODUCTION; BIOTECHNOLOGY; BREAST CANCER; CELL SPECIFICITY; CLINICAL TRIAL; CYTOTOXICITY; DOSAGE SCHEDULE COMPARISON; DRUG ABSORPTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; GENE DELIVERY SYSTEM; GENE SILENCING; GENE TARGETING; HEAD AND NECK CANCER; HEPATITIS C; HUMAN; IMMUNOGENICITY; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG CANCER; LUNG NON SMALL CELL CANCER; MOLECULAR WEIGHT; NEBULIZATION; NEUTROPENIA; NONHUMAN; OSTEOPOROSIS; OVARY CARCINOMA; PAGET BONE DISEASE; PHYSICAL CHEMISTRY; PROTEIN ENGINEERING; REVIEW; TUMOR GROWTH; ULTRASOUND THERAPY; UNSPECIFIED SIDE EFFECT;

EID: 44249097826     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.5.4.371     Document Type: Review

References (117)